Related Experiment Video
Updated: Jan 24, 2026
Synthesis of an Intein-mediated Artificial Protein Hydrogel
Published on: January 27, 2014
Differential regulation of cyclic adenosine monophosphate by phosphodiesterase 3A discriminates thrombin-induced
Rafika Yasmin1, Rima Chattopadhyay1, Vandana2
1Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Background:
Human platelets express 2 thrombin-activated G protein-coupled receptors (GPCRs), protease activated receptor (PAR)1 and PAR4. Previous studies have demonstrated PAR1 activation to be fast on-fast off while PAR4 activation was slower but more sustained. However, how PARs regulate second messengers such as cyclic adenosine monophosphate (cAMP), a negative regulator of platelet activation, remain unknown.
Objectives:
This study investigated how PAR1 and PAR4 activation by thrombin regulates cAMP levels and platelet activation.
Methods:
PAR1 and PAR4 on washed human platelets were inhibited with vorapaxar or BMS-986120, respectively, in the presence or absence of prostaglandin (PG)I2. Platelets were stimulated with various thrombin concentrations, and calcium flux and platelet aggregation were measured. PAR regulation of cAMP in megakaryocytes (MKs) was also studied by genetic disruption of PAR1 or PAR4 using CRISPR/Cas9 editing.
Results:
In the presence of PGI2, cAMP was significantly reduced after thrombin stimulation when platelets or MKs were activated through PAR1, but not PAR4. Calcium flux was highly associated with cAMP level changes. High concentrations of cAMP were associated with low calcium flux with PAR4 stimulation. In contrast, stimulating PAR1 decreased cAMP levels, and this was associated with a more pronounced calcium flux. Phosphodiesterase (PDE)3A is involved in regulating cAMP levels. Blocking PDE3A with a pharmacological inhibitor in platelets or genetic knockout in MKs reversed PAR1-induced decrease of cAMP level, while PAR4 was not affected by PDE3A inhibition.
Conclusion:
The data suggest differences between PAR1 and PAR4 induced thrombin activation are due, in part, to cAMP regulation by PDE3A.
Related Concept Videos
02:04Protein-protein Interfaces
02:04Protein-Protein Interfaces
02:26Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
00:55Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
02:26Conservation of Protein Domains
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...